| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,966 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Aschinger Carl J Jr |
Director |
– • – |
2006-05-31 |
4 |
B |
$0.25 |
$1,275 |
D/D |
5,100 |
29,000 |
2.31 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2006-05-30 |
4 |
B |
$0.25 |
$225 |
D/D |
900 |
23,900 |
2.31 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2006-05-30 |
4 |
B |
$0.26 |
$2,694 |
I/I |
10,000 |
175,511 |
2.58 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2006-05-26 |
4 |
B |
$0.25 |
$10,100 |
D/D |
40,000 |
438,500 |
2.81 |
- |
|
| Larson Brent L |
VP Finance and CFO |
• – – |
2006-05-12 |
4 |
B |
$0.27 |
$1,215 |
D/D |
4,500 |
100,000 |
2.66 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2006-03-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
15,886 |
165,511 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2006-02-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
67,550 |
149,625 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2006-02-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
24,200 |
82,075 |
|
- |
|
| Bupp David C |
CEO and President |
• • – |
2006-02-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,200 |
398,500 |
|
- |
|
| Bupp David C |
officerTitle |
• • – |
2005-12-13 |
4 |
S |
$0.26 |
$520 |
D/D |
(2,000) |
422,700 |
|
- |
|
| Larson Brent L |
officerTitle |
• – – |
2005-12-01 |
4 |
B |
$0.25 |
$1,250 |
D/D |
5,000 |
95,500 |
2.66 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2005-11-14 |
4 |
B |
$0.27 |
$2,295 |
D/D |
8,500 |
424,700 |
2.73 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2005-11-11 |
4 |
B |
$0.28 |
$4,343 |
D/D |
15,700 |
416,200 |
2.73 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2005-05-18 |
4 |
B |
$0.32 |
$12,275 |
D/D |
35,000 |
400,500 |
2.81 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2005-05-17 |
4 |
B |
$0.33 |
$4,950 |
D/D |
15,000 |
365,500 |
2.73 |
- |
|
| Larson Brent L |
VP Finance and CFO |
• – – |
2005-05-09 |
4 |
B |
$0.35 |
$5,250 |
D/D |
15,000 |
90,500 |
2.74 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2005-04-14 |
4 |
B |
$0.40 |
$1,600 |
I/I |
4,000 |
57,875 |
2.58 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2005-04-12 |
4 |
B |
$0.42 |
$1,260 |
I/I |
3,000 |
53,875 |
2.58 |
- |
|
| Jay Jeffrey R |
10% Owner |
– – • |
2005-01-18 |
4 |
B |
$0.55 |
$194,825 |
D/D |
335,000 |
335,000 |
2.45 |
- |
|
| Bupp David C |
CEO and President |
• • – |
2004-11-26 |
4 |
B |
$0.40 |
$1,975 |
I/I |
5,000 |
50,875 |
2.58 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2004-09-16 |
4 |
B |
$0.44 |
$1,320 |
D/D |
3,000 |
23,000 |
2.31 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2004-09-09 |
4 |
B |
$0.45 |
$1,800 |
D/D |
4,000 |
20,000 |
2.31 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2004-09-03 |
4 |
B |
$0.42 |
$3,410 |
D/D |
8,000 |
16,000 |
2.31 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2004-09-02 |
4/A |
B |
$0.43 |
$3,440 |
D/D |
8,000 |
16,000 |
2.31 |
- |
|
| Aschinger Carl J Jr |
Director |
– • – |
2004-09-02 |
4 |
B |
$0.43 |
$3,470 |
D/D |
8,000 |
8,000 |
2.31 |
- |
|
411 Records found
|
|
Page 16 of 17 |
|
|
